Next Treatments
Back to Eczema

EP262

TypePill StagePhase 2 Latest updateAug 24, 2025Phase 2 results posted

History

Earliest recorded event: Oct 25, 2023. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Aug 24, 2025Phase 2 results postedPhase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis ClinicalTrials.gov NCT06144424
  • Jul 31, 2024Phase 2 trial completedPhase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis ClinicalTrials.gov NCT06144424
  • Oct 25, 2023Phase 2 trial startedPhase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis ClinicalTrials.gov NCT06144424

Sources

Trials